STAAR Surgical (NASDAQ:STAA – Get Rating) CEO Caren L. Mason sold 35,000 shares of STAAR Surgical stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $57.49, for a total value of $2,012,150.00. Following the completion of the sale, the chief executive officer now owns 83,645 […]
Brokerages expect STAAR Surgical (NASDAQ:STAA – Get Rating) to post $80.03 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for STAAR Surgical’s earnings. The highest sales estimate is $80.10 million and the lowest is $80.00 million. STAAR Surgical reported sales of $62.37 million during the […]
STAAR Surgical (NASDAQ:STAA – Get Rating) released its quarterly earnings results on Wednesday. The medical instruments supplier reported $0.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.15 by $0.14, MarketWatch Earnings reports. STAAR Surgical had a return on equity of 11.84% and a net margin of 10.63%. The firm had […]
STAAR Surgical (NASDAQ:STAA – Get Rating) had its price objective increased by research analysts at Canaccord Genuity Group from $81.00 to $89.00 in a report released on Tuesday, The Fly reports. The brokerage presently has a “buy” rating on the medical instruments supplier’s stock. Canaccord Genuity Group’s target price points to a potential upside of […]
Needham & Company LLC assumed coverage on shares of STAAR Surgical (NASDAQ:STAA – Get Rating) in a research report sent to investors on Friday morning, Marketbeat Ratings reports. The firm issued a buy rating and a $87.00 target price on the medical instruments supplier’s stock. Other research analysts also recently issued reports about the company. […]